Prevention of nephropathy in patients with type 2 diabetes mellitus

被引:12
|
作者
Tzamaloukas, Antonios H.
Murata, Glen H.
机构
[1] New Mexico Vet Affairs Hlth Care Syst, Nephrol Sect, Albuquerque, NM 87108 USA
[2] New Mexico Vet Affairs Hlth Care Syst, Gen Internal Med Sect, Albuquerque, NM 87108 USA
[3] Univ New Mexico, Sch Med, Dept Med, Albuquerque, NM 87131 USA
关键词
diabetic nephropathy prevention; glycemia; hypertension; lipid metabolism; nephrotoxins; type; 2; diabetes;
D O I
10.1007/s11255-005-2394-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The rising incidence of type 2 diabetes mellitus and of its complications will make it the most important health care challenge in the first quarter of the 21st Century. Diabetic nephropathy left unchecked will overwhelm the renal resources. Simple methods ( proper diet and exercise, prevention of obesity) are successful in preventing type 2 diabetes in the great majority of the persons at risk. In patients with established type 2 diabetes, nephropathy can be prevented or greatly delayed by strict metabolic control, strict control of blood pressure using angiotensin-converting enzyme inhibitors and angiotensin receptor blockers as the first line of drugs, tight control of serum lipids using statins as indicated, low protein diet, avoidance of smoking and other nephrotoxic influences, prevention of abnormalities in calcium/phosphorus metabolism, and prevention of renal anemia by the early use of erythropoietin. Current research offers the promise of definitive prevention of both type 2 diabetes and diabetic nephropathy.
引用
收藏
页码:655 / 663
页数:9
相关论文
共 50 条
  • [21] The Impact of Hypoxemia on Nephropathy in Extremely Obese Patients with Type 2 Diabetes Mellitus
    Leong, Wen Bun
    Nolen, Melissa
    Thomas, G. Neil
    Adab, Paymane
    Banerjee, Dev
    Taheri, Shahrad
    [J]. JOURNAL OF CLINICAL SLEEP MEDICINE, 2014, 10 (07): : 773 - 778
  • [22] Membranous nephropathy occurring with type 2 diabetes mellitus
    Qian, Yujun
    Zuo, Ke
    Li, Shijun
    Zeng, Caihong
    Liu, Zhihong
    Wu, Yan
    [J]. CLINICAL NEPHROLOGY, 2017, 87 (03) : 140 - 146
  • [23] Evolution of incipient nephropathy in type 2 diabetes mellitus
    Lemley, KV
    Abdullah, I
    Myers, BD
    Meyer, TW
    Blouch, K
    Smith, WE
    Bennett, PH
    Nelson, RG
    [J]. KIDNEY INTERNATIONAL, 2000, 58 (03) : 1228 - 1237
  • [24] Polythopic pathogenesis of nephropathy in Type 2 diabetes mellitus
    Ljubic, S
    Sokolic, L
    Pavlic-Renar, I
    Metelko, Z
    Roglic, G
    [J]. DIABETES, 2000, 49 : A377 - A377
  • [25] Prevention of Diabetic Nephropathy by Tight Target Control in an Asian Population With Type 2 Diabetes Mellitus
    Tu, Shih-Te
    Chang, Shun-Jen
    Chen, Jung-Fu
    Tien, Kai-Jen
    Hsiao, Jeng-Yueh
    Chen, Hung-Chun
    Hsieh, Ming-Chia
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (02) : 155 - 161
  • [26] Prevention of cardiovascular risk in patients with type 2 diabetes mellitus with aspirin
    Duly-Bouhanick, B
    Menard, S
    Hadjadj, S
    Soares-Barbosa, S
    Plun-Favreau, J
    Guilloteau, G
    [J]. PRESSE MEDICALE, 2001, 30 (02): : 87 - 91
  • [27] Type 2 Diabetes mellitus - screening and prevention
    Stadler, Marietta
    Prager, Rudolf
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2012, 124 : 4 - 6
  • [28] Type 2 diabetes mellitus prevention programs
    Matte, M.
    Velonakis, E. G.
    [J]. ARCHIVES OF HELLENIC MEDICINE, 2011, 28 (04): : 491 - 501
  • [29] Evidence for the Prevention of Type 2 Diabetes Mellitus
    Shubrook, Jay H.
    Chen, William
    Lim, Alegria
    [J]. JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2018, 118 (11): : 730 - 737
  • [30] Voglibose for prevention of type 2 diabetes mellitus
    Muehlhauser, Ingrid
    [J]. LANCET, 2009, 374 (9688): : 448 - 448